Cargando…

Surge in Incidence and Coronavirus Disease 2019 Hospital Risk of Death, United States, September 2020 to March 2021

BACKGROUND: Studies of the early months of the coronavirus disease 2019 (COVID-19) pandemic indicate that patient outcomes may be adversely affected by surges. However, the impact on in-hospital mortality during the largest surge to date, September 2020–March 2021, has not been studied. This study a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Bela, Murphy, Robert E, Karanth, Siddharth, Shiffaraw, Salsawit, Peters, Richard M, Hohmann, Samuel F, Greenberg, Raymond S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550629/ https://www.ncbi.nlm.nih.gov/pubmed/36225742 http://dx.doi.org/10.1093/ofid/ofac424

Ejemplares similares

Direct and Indirect Effects of the Coronavirus Disease 2019 Pandemic on Private Healthcare Utilization in South Africa, March 2020–September 2021
por: Perofsky, Amanda C, et al.
Publicado: (2022)

Estimation of Coronavirus Disease 2019 Hospitalization Costs From a Large Electronic Administrative Discharge Database, March 2020–July 2021
por: Shrestha, Sundar S, et al.
Publicado: (2021)

Characteristics and Risk Factors for Mortality by Coronavirus Disease 2019 Pandemic Waves in Fulton County, Georgia: A Cohort Study March 2020–February 2021
por: Chishinga, Nathaniel, et al.
Publicado: (2022)

Reported exposure trends among healthcare personnel COVID-19 cases, USA, March 2020–March 2021
por: Billock, Rachael M., et al.
Publicado: (2022)

Relative Risks of COVID-19–Associated Hospitalizations and Clinical Outcomes by Age and Race/Ethnicity—March 2020–March 2021
por: Bozio, Catherine H, et al.
Publicado: (2022)

Humoral Immune Response to Messenger RNA Coronavirus Disease 2019 Vaccination Among Children Aged 5–11 Years in a Multisite Prospective Cohort Study, September 2021–September 2022
por: Lyski, Zoe L, et al.
Publicado: (2023)

Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Reported Coronavirus Disease 2019 Cases in US Children, August 2020–May 2021
por: Couture, Alexia, et al.
Publicado: (2022)

Risk of Clinical Severity by Age and Race/Ethnicity Among Adults Hospitalized for COVID-19—United States, March–September 2020
por: Pennington, Audrey F, et al.
Publicado: (2020)

Trends in Clinical Severity of Hospitalized Patients With Coronavirus Disease 2019—Premier Hospital Dataset, April 2020–April 2021
por: Whitfield, Geoffrey P, et al.
Publicado: (2021)

Efficacy of Messenger RNA–1273 Against Severe Acute Respiratory Syndrome Coronavirus 2 Acquisition in Young Adults From March to December 2021
por: Stephenson, Kathryn E, et al.
Publicado: (2023)

Cluster of coronavirus disease 2019 (Covid-19) in the French Alps, 2020
por: Danis, Kostas, et al.
Publicado: (2020)

Risk Factors for Severe Coronavirus Disease 2019 Among Human Immunodeficiency Virus-Infected and -Uninfected Individuals in South Africa, April 2020–March 2022: Data From Sentinel Surveillance
por: Walaza, Sibongile, et al.
Publicado: (2022)

Epidemiological Trends of Coronavirus Disease 2019 in Sierra Leone From March 2020 to October 2021
por: Liu, Zhiguo, et al.
Publicado: (2022)

Surface and Air Contamination With Severe Acute Respiratory Syndrome Coronavirus 2 From Hospitalized Coronavirus Disease 2019 Patients in Toronto, Canada, March–May 2020
por: Kotwa, Jonathon D, et al.
Publicado: (2021)

Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Homeless Shelters in Chicago, Illinois—March–May, 2020
por: Ghinai, Isaac, et al.
Publicado: (2020)

Notes from the Field: CDC Polio Surge Response to Expanding Outbreaks of Type 2 Circulating Vaccine-Derived Poliovirus — Africa and Philippines, September 2019–March 2020
por: Meyer, Erika, et al.
Publicado: (2020)

Population-Based Estimates of SARS-CoV-2 Seroprevalence in Houston, TX as of September 2020
por: Symanski, Elaine, et al.
Publicado: (2021)

Opioid Injection-Associated Bacterial Infections in England, 2002–2021: A Time Series Analysis of Seasonal Variation and the Impact of Coronavirus Disease 2019
por: Lewer, Dan, et al.
Publicado: (2023)

Risk for Stillbirth Among Women With and Without COVID-19 at Delivery Hospitalization — United States, March 2020–September 2021
por: DeSisto, Carla L., et al.
Publicado: (2021)

The Effects of ICU Crisis Reorganization on Outcomes in Patients Not Infected With Coronavirus Disease 2019 During the Initial Surge of the Coronavirus Disease 2019 Pandemic
por: Rana, Sameer, et al.
Publicado: (2021)

Olfactory Dysfunction in Coronavirus Disease 2019 Patients: Observational Cohort Study and Systematic Review
por: Chung, Tom Wai-Hin, et al.
Publicado: (2020)

Indications for healthcare surge capacity in European countries facing an exponential increase in coronavirus disease (COVID-19) cases, March 2020
por: Verelst, Frederik, et al.
Publicado: (2020)

Impact of COVID-19 on an infection prevention and control program, Iowa 2020-2021
por: Alsuhaibani, Mohammed, et al.
Publicado: (2022)

Coronavirus disease 2019 (COVID-19): update for anesthesiologists and intensivists March 2020
por: Thomas-Rüddel, D., et al.
Publicado: (2020)

Dying at Home Due to Coronavirus Disease 2019
por: Edwards, Jessie K, et al.
Publicado: (2022)

Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Presence of Anti–SARS-CoV-2 Antibodies Among University Student Dormitory Residents, September–November 2020
por: Segaloff, Hannah E, et al.
Publicado: (2021)

Testing for Cryptococcosis at a Major Commercial Laboratory—United States, 2019–2021
por: Benedict, Kaitlin, et al.
Publicado: (2022)

Coronavirus Disease 2019–Associated Invasive Fungal Infection
por: Baddley, John W, et al.
Publicado: (2021)

Contact-Tracing Outcomes Among Household Contacts of Fully Vaccinated Coronavirus Disease 2019 (COVID-19) Patients: San Francisco, California, 29 January–2 July 2021
por: Sachdev, Darpun D, et al.
Publicado: (2021)

Excess Mortality in California During the Coronavirus Disease 2019 Pandemic, March to August 2020
por: Chen, Yea-Hung, et al.
Publicado: (2020)

Community-Acquired Pneumonia in Canada During Coronavirus Disease 2019
por: Mandell, Lionel A, et al.
Publicado: (2022)

Coronavirus Disease 2019-Associated Pulmonary Aspergillosis: Reframing the Debate
por: Clancy, Cornelius J, et al.
Publicado: (2022)

Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma
por: Bonny, Tania S, et al.
Publicado: (2020)

Coronavirus Disease 2019 Severity and Risk of Subsequent Cardiovascular Events
por: Wiemken, Timothy L, et al.
Publicado: (2022)

Contribution of Coronavirus-Specific Immunoglobulin G Responses to Complement Overactivation in Patients with Severe Coronavirus Disease 2019( )
por: Castanha, Priscila M S, et al.
Publicado: (2022)

Outbreak investigation of CRAB at an acute-care hospital ICU during the COVID-19 pandemic–Chicago, Illinois, March 2020–September 2021
por: Adil, Hira, et al.
Publicado: (2022)

Examination of Trends in Diabetes Incidence Among Children During the COVID-19 Pandemic in Ontario, Canada, From March 2020 to September 2021
por: Shulman, Rayzel, et al.
Publicado: (2022)

Acknowledgment to reviewers—October 2019 to September 2020
Publicado: (2020)

Symptom Duration and Resolution With Early Outpatient Treatment of Convalescent Plasma for Coronavirus Disease 2019: A Randomized Trial
por: Baksh, Sheriza N, et al.
Publicado: (2023)

Pfizer-BioNTech Coronavirus Disease 2019 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Long-term Care Facility Staff With and Without Prior Infection in New York City, January–June 2021
por: Peebles, Kathryn, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u9qjbkeefil51r91b3aavjpuv7